Loomis Sayles & CO L P Ironwood Pharmaceuticals Inc Transaction History

Loomis Sayles & CO L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $11.9 Million - $24.6 Million	-1,522,716 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$14.31 - $17.65 $83,126 - $102,528	-5,809 Reduced 0.38%	1,522,716 $28.1 Million
Q2 2018 Aug 14, 2018	SELL	$11.83 - $16.2 $61,847 - $84,693	-5,228 Reduced 0.34%	1,528,525 $29.2 Million
Q1 2018 May 11, 2018	SELL	$11.13 - $13.63 $513,137 - $628,397	-46,104 Reduced 2.92%	1,533,753 $23.7 Million
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $345,648 - $414,436	28,425 Added 1.83%	1,579,857 $23.7 Million

Q3 2017 Nov 14, 2017	SELL	$12.07 - $14.87 $543,306 - $669,343	-45,013 Reduced 2.82%	1,551,432 $24.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,596,445	1,596,445 $30.1 Million

296

170M

27.1M

2.28M

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $953M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.